PT1003496E - Medicamento para tratamento de neoplasia intra-epitelial prostatica - Google Patents

Medicamento para tratamento de neoplasia intra-epitelial prostatica

Info

Publication number
PT1003496E
PT1003496E PT99924157T PT99924157T PT1003496E PT 1003496 E PT1003496 E PT 1003496E PT 99924157 T PT99924157 T PT 99924157T PT 99924157 T PT99924157 T PT 99924157T PT 1003496 E PT1003496 E PT 1003496E
Authority
PT
Portugal
Prior art keywords
epitelial
treatment medication
neoplasia treatment
prostatic intra
neoplasia
Prior art date
Application number
PT99924157T
Other languages
English (en)
Portuguese (pt)
Inventor
Mitchell S Steiner
Raghow Sharon
Original Assignee
Univ Tennessee Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Corp filed Critical Univ Tennessee Res Corp
Publication of PT1003496E publication Critical patent/PT1003496E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99924157T 1998-05-07 1999-05-07 Medicamento para tratamento de neoplasia intra-epitelial prostatica PT1003496E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8460298P 1998-05-07 1998-05-07

Publications (1)

Publication Number Publication Date
PT1003496E true PT1003496E (pt) 2005-04-29

Family

ID=22186034

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99924157T PT1003496E (pt) 1998-05-07 1999-05-07 Medicamento para tratamento de neoplasia intra-epitelial prostatica

Country Status (26)

Country Link
US (1) US6265448B1 (de)
EP (3) EP1003496B1 (de)
JP (2) JP4482229B2 (de)
AT (1) ATE283043T1 (de)
AU (1) AU761435B2 (de)
BG (1) BG65597B1 (de)
CA (1) CA2323809C (de)
CZ (1) CZ300960B6 (de)
DE (2) DE69922131T2 (de)
DK (1) DK1003496T3 (de)
EA (1) EA003466B1 (de)
ES (1) ES2145730T3 (de)
HR (1) HRP20000729A2 (de)
HU (1) HUP0102068A3 (de)
IL (3) IL138437A0 (de)
IS (2) IS2213B (de)
NO (1) NO20005625L (de)
NZ (1) NZ527522A (de)
PL (1) PL207462B1 (de)
PT (1) PT1003496E (de)
SI (1) SI1003496T1 (de)
SK (1) SK16642000A3 (de)
TR (1) TR200003269T2 (de)
UA (1) UA74532C2 (de)
WO (1) WO1999056739A1 (de)
YU (1) YU68600A (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
DE69922131T2 (de) * 1998-05-07 2005-11-24 The University Of Tennessee Research Corp., Knoxville Medikament zur behandlung intraepithelialer prostataneoplasie
US20030130316A1 (en) * 2000-03-20 2003-07-10 Steiner Mitchell S. Method for chemoprevention of prostate cancer
US6413534B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US20040092602A1 (en) * 1998-05-07 2004-05-13 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US20040176470A1 (en) * 1998-05-07 2004-09-09 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
WO2001017480A2 (en) * 1999-09-09 2001-03-15 Androsolutions, Inc. Methods and compositions for preventing and treating urinary tract disorders
US6642274B1 (en) 1999-09-09 2003-11-04 Gary W. Neal Methods and compositions for preventing and treating prostate disorders
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20040096510A1 (en) * 2001-11-29 2004-05-20 Steiner Mitchell S. Prevention and treatment of androgen-deprivation induced osteoporosis
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
US20040213841A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S Methods for treating hot flashes and gynecomastia
ES2319785T3 (es) 2001-11-29 2009-05-12 Gtx, Inc. Prevencion y tratamiento de osteoporosis inducida por privacion de androgenos.
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) * 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
US7070816B2 (en) * 2003-12-05 2006-07-04 New Chapter, Inc. Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US20050208159A1 (en) * 2004-03-16 2005-09-22 Kang Kyung S Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
US20060019989A1 (en) * 2004-07-21 2006-01-26 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof
US20060105045A1 (en) * 2004-11-08 2006-05-18 Buchanan Charles M Cyclodextrin solubilizers for liquid and semi-solid formulations
US20060105992A1 (en) * 2004-11-08 2006-05-18 Buchanan Charles M Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
US20060270641A1 (en) * 2005-05-31 2006-11-30 Steiner Mitchell S Method for chemoprevention of prostate cancer
USD969722S1 (en) 2021-09-28 2022-11-15 Wagner Delima Stabilizing wedge pad

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329364A (en) 1974-09-11 1982-05-11 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US4474813A (en) 1980-10-24 1984-10-02 Schering Corporation Pharmaceutical preparations comprising flutamide
FI77839C (fi) 1982-05-27 1989-05-10 Farmos Oy Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
US5491173A (en) 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US4990538A (en) 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
AU687767B2 (en) * 1992-12-01 1998-03-05 Oy Biotie Therapies Ltd Syndecan stimulation of cellular differentiation
US5595722A (en) 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
JPH08510451A (ja) 1993-05-13 1996-11-05 ネオルックス コーポレイション 異常増殖性平滑筋細胞に関連した病因の予防及び治療
CZ285508B6 (cs) 1993-08-09 1999-08-11 Edward Baral Použití trifenylethylenových antiestrogenů pro zvyšování citlivosti rakovinných buněk k lyzi zprostředkované zabíječskými buňkami
US5650425A (en) * 1994-04-04 1997-07-22 Pharmos Corporation Permanently ionic derivatives of steroid hormones and their antagonists
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
ZA984650B (en) 1997-06-19 1998-12-08 Orion Corp Intratumoral administration of triphenylethylenes for the treatment of cancer
DE69922131T2 (de) * 1998-05-07 2005-11-24 The University Of Tennessee Research Corp., Knoxville Medikament zur behandlung intraepithelialer prostataneoplasie

Also Published As

Publication number Publication date
JP2002513755A (ja) 2002-05-14
YU68600A (sh) 2003-12-31
DE69922131T2 (de) 2005-11-24
IL138437A (en) 2008-12-29
EA003466B1 (ru) 2003-06-26
CA2323809C (en) 2007-09-18
TR200003269T2 (tr) 2001-02-21
CZ300960B6 (cs) 2009-09-23
EP1003496A1 (de) 2000-05-31
JP2008163048A (ja) 2008-07-17
US6265448B1 (en) 2001-07-24
ES2145730T3 (es) 2005-06-16
EP1475087A2 (de) 2004-11-10
NO20005625D0 (no) 2000-11-07
SK16642000A3 (sk) 2002-08-06
EP1003496B1 (de) 2004-11-24
AU4072699A (en) 1999-11-23
BG65597B1 (bg) 2009-02-27
DE1003496T1 (de) 2000-11-02
IL138437A0 (en) 2001-10-31
HUP0102068A3 (en) 2002-11-28
EP2277514A1 (de) 2011-01-26
ATE283043T1 (de) 2004-12-15
UA74532C2 (en) 2006-01-16
CA2323809A1 (en) 1999-11-11
EP1475087A3 (de) 2007-07-11
HUP0102068A2 (hu) 2002-05-29
IS5700A (is) 2000-11-01
EA200000100A1 (ru) 2000-08-28
NO20005625L (no) 2001-01-05
IL193231A0 (en) 2009-02-11
CZ20004118A3 (cs) 2002-07-17
JP4482229B2 (ja) 2010-06-16
WO1999056739A1 (en) 1999-11-11
DE69922131D1 (de) 2004-12-30
NZ527522A (en) 2005-04-29
SI1003496T1 (en) 2005-10-31
IS2213B (is) 2007-03-15
HRP20000729A2 (en) 2001-06-30
IS8354A (is) 2006-03-15
PL344000A1 (en) 2001-09-10
AU761435B2 (en) 2003-06-05
ES2145730T1 (es) 2000-07-16
PL207462B1 (pl) 2010-12-31
BG105022A (bg) 2001-07-31
DK1003496T3 (da) 2005-04-04

Similar Documents

Publication Publication Date Title
PT1003496E (pt) Medicamento para tratamento de neoplasia intra-epitelial prostatica
BR9806118A (pt) Processos para tratamento de pigmentação de pele
BR9812122A (pt) Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata
WO2000038718A3 (en) Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
TWI315987B (en) The use of toremifene for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer
NO20002409L (no) FremgangsmÕte for Õ produsere arsen trioksyd formuleringer og metoder for Õ behandle cancer ved Õ bruke arsen trioksyd eller melarsoprol
DE60142084D1 (de) Anwendung von glp-2 in verbindung mit einem anderen therapeutischen mittel in knochenkrankheiten
IS4972A (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
EP0943331A3 (de) Arzneimittel enthaltend Oxaliplatin
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
IS6970A (is) Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
IL155263A0 (en) Pharmaceutical solutions of modafinil compounds
CA2339384A1 (en) Improved method for targeted topical treatment of disease
ATE121727T1 (de) Chelatbildner, die eine ortho-bindende funktionelle gruppe besitzen und komplexe davon.
BR0109789A (pt) Método para o tratamento de câncer de mama, e, uso de fulvestrante
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
BR0210642A (pt) Oligo- ou/e polirribonucleotìdeos xenogênicos como agente para o tratamento de tumores malignos
WO2002092129A3 (en) Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist
BR9908664A (pt) O uso do nitroprussiato de sódio e a respectiva aplicação
MX9709941A (es) Nueva composicion farmaceutica con efecto anestesico.
BR0300583A (pt) Composto de paládio com desoxialiina, processo de preparação deste composto e agente com atividade antiproliferativa e citotóxica sobre células tumorais, obtido a partir do composto
GEP20043311B (en) Combination for Prevention of Bleeding and TUR-Syndrome during Transurethral Resection of Prostate